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ABSTRACT
Background: Previous studies found larger lung
volumes at school-age in formerly breastfed children,
with some studies suggesting an effect modification by
maternal asthma. We wanted to explore this further in
children who had undergone extensive lung function
testing. The current study aimed to assess whether
breastfeeding was associated with larger lung volumes
and, if so, whether all compartments were affected. We
also assessed association of breastfeeding with
apparent diffusion coefficient (ADC), which measures
freedom of gas diffusion in alveolar-acinar
compartments and is a surrogate of alveolar
dimensions. Additionally, we assessed whether these
effects were modified by maternal asthma.
Methods: We analysed data from 111 children and
young adults aged 11–21 years, who had participated
in detailed lung function testing, including spirometry,
plethysmography and measurement of ADC of 3Helium
(3He) by MR. Information on breastfeeding came from
questionnaires applied in early childhood
(age 1–4 years). We determined the association
between breastfeeding and these measurements using
linear regression, controlling for potential confounders.
Results: We did not find significant evidence for an
association between duration of breastfeeding and lung
volumes or alveolar dimensions in the entire sample.
In breastfed children of mothers with asthma, we
observed larger lung volumes and larger average
alveolar size than in non-breastfed children, but the
differences did not reach significance levels.
Conclusions: Confirmation of effects of breastfeeding
on lung volumes would have important implications for
public health. Further investigations with larger sample
sizes are warranted.
INTRODUCTION
Breastfeeding has many beneﬁcial effects for
children and mothers.1 The impact on
respiratory health is, however, less clear.
Studies have shown that breastfed children
have fewer and less severe respiratory infec-
tions than their non-breastfed peers.2–5 The
inﬂuence of breastfeeding on lung develop-
ment has been investigated by few research-
ers, with mixed results.6–11 Most studies
reported larger normalised lung volumes in
breastfed children, usually higher forced vital
capacity (FVC) or forced expiratory volume at
1 s (FEV1).
6 8–11 In a recent study, we found
that children breastfed over 3 months had
higher forced mid-expiratory ﬂows (FEF50) at
school-age.12 There was also evidence of an
effect modiﬁcation by maternal asthma: in
children whose mothers had asthma, the
increase in FEF50 was greater and accompan-
ied by increased FEV1 and FVC.
12
From these studies, it remains unclear if the
reported increase of volumes with breastfeed-
ing involves different lung compartments
proportionally. For instance, increased lung
volumes might be explained by more alveoli or
by larger alveoli due to structural differences
or hyperinﬂation. Proportional increases in all
lung volumes would suggest genuinely larger
lungs, while increases limited to residual
volume (RV), functional residual capacity
(FRC) and total lung capacity (TLC) would
suggest the presence of hyperinﬂation. We
used the novel technique of 3He MR, which
measures freedom of gas diffusion in alveolar-
acinar compartments and provides a surrogate
measure of alveolar size, to determine whether
the reported increase in lung volume is
associated with proportionately increased
alveolar size (suggesting lung growth) or dis-
proportionately increased alveolar size (sug-
gesting hyperinﬂation). Using this technique,
we recently reported evidence for continued
alveolarisation throughout childhood and
adolescence13 and evidence for catch-up
KEY MESSAGES
▸ This study is the first to report data on the pos-
sible association between breastfeeding and
alveolar size.
▸ While the study does not provide strog evidence
of an association, it suggests that breastfeeding
may be associated with increased lung volumes
and alveolar size, particularly in children of
mothers with asthma.
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alveolarisation in ex-preterm children.14 We have now rea-
nalysed this data set to investigate the association between
breastfeeding and plethysmographic lung volumes and
alveolar dimensions. No previous studies have investigated
the effect of breastfeeding on these measurements.
The aim of our study were thus to determine (1)
whether plethysmographic lung volumes and alveolar
size are associated with duration of breastfeeding, and
(2) whether the potential association between breast-
feeding and lung volumes differs depending on
mother’s history of asthma.
MATERIALS AND METHODS
The study was approved by the Ethics Committee of the
Leicestershire Health Authority and written consent had
been obtained from all participants and their parents.
Study population
For this study, we analysed a data set of 111 children and
young adults (aged 11–21 years) from Leicestershire,
UK, who had participated in a complex study on alveolar
dimensions, measured by 3He MR, the ‘Helium
study’.13 14 The original study was not designed speciﬁc-
ally for analysing the association with breastfeeding. We
included for analysis participants who had been born at
32 weeks of gestation or later, had a birth weight of over
1500 g, who had no congenital anomalies or chronic
lung diseases, such as cystic ﬁbrosis or bronchopulmon-
ary dysplasia, and in whom prospectively collected infor-
mation on breastfeeding was available.
The participants had been recruited from the Leicester
Respiratory Cohorts, consisting of two population-based
cohorts based on random samples of children born in
Leicestershire between 1987 and 1989 (the 1990 cohort),
and between 1993 and 1997 (the 1998 cohort). The
Leicestershire Health Authority Child Health Database,
later called the Leicester Specialist Community Child
Health Services Database, had been used to draw the
sample and obtain baseline routine data.15 Parents of
participating children received the ﬁrst set of respiratory
questionnaires in 1990 and 1998, respectively, when
the children were 0–5 years old. The participants were
then followed up repeatedly with questionnaires, every
2–4 years.
In total, 410 participants from the Leicester
Respiratory Cohorts had been invited to the Helium
study. A total of 125 (30.5%) participated, and we
obtained 3HeMR measurements in 114 participants. Of
the 114 with 3He MR measurements, 111 were eligible
for the present study, based on criteria described above
and availability of breastfeeding data.
Health records and questionnaire data
We extracted perinatal data for all participants from
Leicestershire Health Authority Child Health Database,
including mother’s ethnicity, birth weight and gesta-
tional age. We had assessed respiratory symptoms, and
individual and family-related exposures initially in 1990
and 1998, and in several follow-up questionnaires in
2001, 2003 and 2006. At the time of the helium study, all
participants and their parents were asked to complete a
new questionnaire, providing information on health
history, environmental exposures and demographic data.
Breastfeeding was deﬁned as total duration of breastfeed-
ing, regardless of exclusivity. We recorded duration of
breastfeeding in the ﬁrst questionnaire (applied at age 0–5
years). The question asked if the child had been breastfed
and, if yes, for how long, with the following response
options: less than a month; 1–3 months; 4–6 months and more
than 6 months. Owing to the small sample size, we com-
bined the responses into one of three categories: (1) no
breastfeeding, (2) breastfeeding for less than or equal to 3 months
and (3) breastfeeding for more than 3 months.
We considered as potential confounders those factors
that might be a common cause of both exposure (dur-
ation of breastfeeding) and outcomes (lung and alveolar
volumes) or be on the pathway of a common cause. For
our analysis these included: Townsend score—an area-
based deprivation score16—birth weight, preterm status,
smoking during pregnancy, maternal asthma, maternal
ethnicity and early-onset wheeze, described in more
detail below. Participants were considered preterm if
their gestational age, extracted from the birth registry,
was under 37 weeks. Information on mother’s history of
smoking during pregnancy (yes/no) was collected in the
initial questionnaire and updated at the time of mea-
surements. Maternal history of asthma (yes/no) was self-
reported based on the question: “Has the child’s mother
ever suffered from any of the following conditions :(…)
wheezing; asthma?” We coded maternal asthma as ‘yes’ if
the mother reported wheezing or asthma. Maternal eth-
nicity was extracted from birth records and categorised
into White and south-Asian; the south-Asian group, which
includes people of Indian/Sri Lanka, Pakistani or
Bangladesh origin, is the largest ethnic minority in
Leicestershire and one of the sampling strata of the
Leicester Respiratory Cohorts. We deﬁned early-onset
wheeze as any wheezing with onset during the ﬁrst year of
life. Early-onset wheeze was included in the analysis in an
attempt to control for a possible reverse causation, when
early-onset wheeze, a possible precursor of future lung
problems resulting in decreased lung function, might
inﬂuence the duration of breastfeeding. In order to
avoid over-adjustment, we did not include in the analysis
variables that theoretically might be on the causal path,
such as participant’s history of asthma.17
Physiological measurements
At the time of the study, height and weight were mea-
sured, and lung mechanics were assessed by performing
spirometry and full-body plethysmography ( Jaeger
Masterscreen Body, Wuerzburg, Germany). The highest
values of forced expired volume in 1 s (FEV1) and forced
vital capacity (FVC) were reported, together with forced
expiratory ﬂow at 50% vital capacity (FEF50) from the
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manoeuvre with the largest sum of FEV1 and FVC. From
plethysmography, the mean value of functional residual
capacity (FRC), the largest vital capacity (VC), and the
residual volume (RV) and total lung capacity (TLC) asso-
ciated with the largest VC were reported. The measure-
ments conformed to the American Thoracic Society/
European Respiratory Society task force speciﬁca-
tions,18 19 and were reviewed for repeatability and quality
control by a specialist respiratory physiologist (CSB).
To assess the average dimensions of the alveoli, we
used the hyperpolarised 3Helium MR technique
(3HeMR), which measures the restricted diffusion of
hyperpolarised 3He in a constrained space such as the
alveoli. The measurement provides a surrogate of alveo-
lar dimension, the apparent diffusion coefﬁcient (ADC).
The participant is required to lie supine and at the end
of a normal expiration, she/he inhales a bolus of
600 mL of a mixture of hyperpolarised 3He and 4He,
and holds the breath for approximately 10 s. 4He is an
abundant, naturally occurring non-radioactive helium
isotope, while 3He is a rare non-radioactive isotope of
helium that can be polarised.20 The MR measurements
were performed with a 0.15 T permanent magnet system
(Intermagnetics General Corporation, New York,
New York, USA) using a modiﬁed rapid acquisition with
refocused echoes (RARE) sequence (64 echoes, echo
time=14 ms, acquisition time=896 ms, ﬁxed gradient
strength (b=0.3 s.cm−2), and slice select and phase gradi-
ents turned off).13 The technique is non-invasive and
radiation-free, but expensive and used in only few
centres worldwide. At least three technically satisfactory
ADC values were obtained for each participant and the
mean value was reported. We corrected ADC values for
differences in 3He concentration and bolus size in
relation to FRC.13 14 The measurements were highly
repeatable, with a within-subject coefﬁcient of variation
of 3.1%.13
Statistical analysis
The association between duration of breastfeeding and
lung volumes and alveolar size was analysed using multi-
variable linear regression. The outcomes of interest were
spirometric measures (FVC, FEV1 and FEF50), plethysmo-
graphic measures (FRC, VC, RV and TLC), and alveolar
size (ADC). To assess relative (percent) differences
between levels of breastfeeding, we ﬁrst log-transformed
the outcomes, performed the regressions and then
exponentiated estimated coefﬁcients. Thus, the (exponen-
tiated) regression constant and slope represent geometric
means and relative differences, respectively. The analysis
was performed in three steps: ﬁrst we ran a model control-
ling only for variables needed to standardise lung function
measurements, namely age, sex and height (basic model).
Second, we ran a model including potential confounders,
namely preterm status, birth weight, Townsend score,
smoking during pregnancy, maternal asthma, maternal
ethnicity and early-onset wheeze (adjusted model); third, we
ran a model in which we added an interaction term
between breastfeeding and maternal asthma to test for
effect modiﬁcation by maternal asthma (effect-modiﬁcation
model). The analyses of ADC were adjusted, additionally,
for the natural logarithm of FRC, because of an expected
increase in ADC with FRC.13 Thus, regression coefﬁcients
for the ADC models reﬂect relative differences in ADC
over and above those accounted for by changes in FRC
due to lung growth. These relative differences in ADC due
to the risk factors in the regression model are also
expressed in terms of estimated differences in mean alveo-
lar volume using the relationship ADC ratio=(volume
ratio)0.415 derived in Narayanan et al.13
Based on the third model with an interaction term
between breastfeeding and maternal asthma, we calcu-
lated the means of the outcome measures for children
of mothers with and without asthma. All analyses were
performed using Stata V.12 (Stata Corporation, Austin,
Texas, USA).
RESULTS
Sample characteristics
Detailed data on sample characteristics are presented
(table 1). Among participants 24 (22%) had never been
breastfed, 37 (33%) had been breastfed 3 months or
less, and 50 (45%) had been breastfed over 3 months;
the mothers of 22 (20%) reported having asthma. Girls,
children of mothers without asthma and of mothers who
did not smoke during pregnancy tended to be breastfed
longer. We did not ﬁnd evidence for differences in spir-
ometry or plethysmographic measurements and ADC
between categories of breastfeeding.
Breastfeeding and lung volumes
Basic and adjusted model
Table 2 presents the results of the basic and adjusted
models. When compared with participants who had not
been breastfed, the TLC of participants breastfed
>3 months was on average larger by over 6% in the basic
and adjusted model. We found no strong evidence for
an association between duration of breastfeeding and
any of the other lung function outcomes, regardless of
adjustment for potential confounders. Although partici-
pants breastfed for >3 months tended to have larger
lung volumes and ﬂows than non-breastfed participants,
95% CIs (95% CI) for differences included 0 and the
p values were all >0.1.
Effect-modification model
The results from the model that tested an effect modiﬁca-
tion by maternal asthma are presented in table 3 and
ﬁgure 1. We did not ﬁnd signiﬁcant evidence for an effect
modiﬁcation by maternal asthma. Among participants
born to mothers with asthma there was a tendency towards
larger lung volumes and alveolar size in those who were
breastfed >3 months compared with those who were not
breastfed but in offspring of mothers without asthma these
differences were close to zero. When compared with
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participants who had not been breastfed, the FRC of parti-
cipants breastfed >3 months was on average larger by 2.4%
in offspring of non-asthmatic mothers but larger by 15.2%
in those born to asthmatic mothers. Similar differences
between children of asthmatic and non-asthmatic mothers
were found for the other lung volumes (table 3). The
ADC of participants breastfed over 3 months was 0.5%
lower in those born to non-asthmatic mothers but 11.0%
higher in those born to asthmatic mothers. Using the
formula ADC ratio=(volume ratio)0.415, we determined
that among participants breastfed for over 3 months the
average alveolar size was smaller by 1.2% in participants of
non-asthmatic mothers but 28.6% larger in participants of
asthmatic mothers compared to participants who were not
breastfed (table 3).
DISCUSSION
Findings and interpretation
In this study we did not ﬁnd evidence of an association
between breastfeeding duration and lung volumes or
alveolar dimensions at school age, except for larger TLC
values in children breastfed over 3 months. However,
we observed a consistent trend towards larger alveoli
and larger lung volumes, both spirometric and ple-
thysmographic, in children of asthmatic mothers who
had been breastfed over 3 months compared to those
not breastfed. While the ﬁndings were comparable to
previous reports,12 they did not reach statistical signiﬁ-
cance for any of the tested outcomes in this small study.
Several authors have found positive associations
between breastfeeding and lung function in school-age
children.6–11 We have reported previously in a larger
study that breastfed children had increased FEF50 com-
pared with non-breastfed children. This increase was
larger in participants born to mothers with asthma, with
evidence for a dose–response relationship with duration
of breastfeeding. Furthermore, it was accompanied by
increases in FVC and FEV1. In the present study we
found differences that were similar or larger in magni-
tude than in our earlier study, but they failed to reach
Table 1 Characteristics of study population, by duration of breastfeeding (N=151)
Breastfeeding categories
Total (N=111) Never (N=24) ≤3 months (N=37) >3 months (N=50) p Value*
Age† (years) 14.1 (2.5) 14.7 (2.7) 14.3 (2.9) 13.5 (2.0) 0.111
Height† (cm) 160.8 (10.9) 164.0 (13.5) 158.7 (10.8) 160.9 (9.4) 0.190
Weight† (kg) 53.8 (13.1) 58.2 (17.2) 52.8 (13.1) 52.5 (10.5) 0.189
Gestational age† (weeks) 38.5 (2.3) 39.0 (1.9) 38.4 (2.5) 38.9 (2.0) 0.371
Birth weight (g) 3235.8 (599.2) 3111.2 (622.2) 3212.7 (605.1) 3313.8 (583.9) 0.386
Sex‡
Male 51 (46.0) 23 (63.9) 14 (32.6) 35 (48.1) 0.021
Female 60 (54.0) 13 (36.1) 29 (67.4) 37 (51.4)
Ethnicity‡
South-Asian 24 (21.6) 5 (20.8) 9 (37.5) 10 (41.7) 0.884
White 87 (78.4) 19 (21.8) 28 (32.2) 40 (45.9)
Smoking during pregnancy‡
No 100 (90.1) 18 (18.0) 36 (36.0) 46 (46.0) 0.014
Yes 11 (9.9) 6 (54.5) 1 (9.1) 4 (36.4)
Early-onset wheeze‡
No 88 (79.3) 19 (21.6) 31 (35.2) 38 (43.2) 0.676
Yes 23 (20.7) 5 (21.7) 6 (26.1) 12 (52.2)
Maternal asthma‡
No 88 (79.3) 15 (17.05) 31 (35.23) 42 (47.73) 0.052
Yes 22 (19.8) 9 (40.91) 6 (27.27) 7 (31.82)
Missing 1 (0.9) 0 (0.0) 0 (0.0) 1 (100.0)
FVC§ (L) 3.5 (0.7) 3.76 (0.92) 3.41 (0.74) 3.53 (0.63) 0.183
FEV1§ (L) 3.0 (0.6) 3.23 (0.75) 2.94 (0.62) 3.04 (0.52) 0.197
FEF50§ (L/s) 3.6 (0.6) 3.78 (0.74) 3.50 (0.62) 3.61 (0.53) 0.220
FRC§ (L) 2.2 (0.5) 2.37 (0.59) 2.17 (0.51) 2.19 (0.40) 0.227
RV§ (L) 1.2 (0.2) 1.31 (0.29) 1.22 (0.25) 1.22 (0.19) 0.233
TLC§ (L) 4.7 (0.9) 4.94 (1.15) 4.50 (0.94) 4.64 (0.78) 0.196
ADC¶ (cm2/s) 0.096 (0.012) 0.095 (0.012) 0.096 (0.012) 0.095 (0.013) 0.444
*The p value is based on a χ2 test.
†Mean (SD).
‡N (%); the percentages represent breastfeeding frequencies within levels of confounder (row percentages).
§The means of the outcome variables are predicted values adjusted for age, sex, height, weight using linear regression.
¶The ADC analysis was performed using the natural logarithm, adjusting for age, sex, height and ln FRC; the estimates were
back-transformed from the logarithmic scale to the original scale, therefore the estimated means are geometric means.
ADC, apparent diffusion coefficient; ETS, exposure to tobacco smoke; FEF50, forced mid-expiratory flow; FEV1, forced expiratory volume at
1 s; FRC, functional residual capacity; FVC, forced vital capacity; RV, residual volume; TLC, total lung capacity; VC, vital capacity.
4 Dogaru CM, Narayanan M, Spycher BD, et al. BMJ Open Resp Res 2015;2:e000081. doi:10.1136/bmjresp-2015-000081
Open Access
group.bmj.com on January 3, 2016 - Published by http://bmjopenrespres.bmj.com/Downloaded from 
statistical signiﬁcance. This is not surprising as the two
studies are not independent: 81% of the children in the
present study were also included in the previous study.
However, because of the costly and time consuming
nature of 3HeMR measurements, the sample size in the
present study was more modest and thus, the statistical
power reduced.
Our results were suggestive of an increase in all
volumes associated with breastfeeding in children of
asthmatic mothers. The precision of our estimates was
too small to distinguish between the hypotheses of con-
gruent volume increases in all components versus hyper-
inﬂation. The relative increases were largest for mean
alveolar volume, suggesting that volume increases were
not accompanied by a proportional increase in alveolar
number.
If we consider that these ﬁndings do reﬂect real differ-
ences in the population, it is difﬁcult to speculate why
this might be so, and why this difference is seen only in
children of mothers with asthma. A possible explanation
is that there were inﬂuences associated with secretion of
lung growth factors in breast milk of asthmatic mothers.
Another possible explanation could be residual con-
founding by severity of maternal asthma; perhaps
mothers with more severe asthma were less likely to
breastfeed, but more likely to have children with low
Table 2 Association between breastfeeding and lung function measurements in all participants, basic model and fully
adjusted model*
Lung function (unit)
Basic model† Adjusted model‡
estimates (CI) p Value estimates (CI) p Value
FVC§ (L)
No BF (mean) 3.31 (3.12 to 3.49) 3.39 (3.18 to 3.61)
BF ≤3 months (% difference) 3.07 (−4.30 to 10.44) 0.407 4.20 (−3.03 to 11.43) 0.245
BF >3 months (% difference) 4.44 (−2.65 to 11.52) 0.210 4.20 (−2.40 to 10.80) 0.203
FEV1§ (L)
No BF (mean) 2.82 (2.66 to 2.98) 2.93 (2.73 to 3.13)
BF ≤3 months (% difference) 4.33 (−3.43 to 12.08) 0.264 5.42 (−2.34 to 13.17) 0.160
BF >3 months (% difference) 5.66 (−1.80 to 13.12) 0.126 5.41 (−1.67 to 12.48) 0.124
FEF50§ (L/s)
No BF (mean) 3.20 (2.86 to 3.55) 3.46 (2.98 to 3.95)
BF ≤3 months (% difference) 9.16 (−6.04 to 24.35) 0.217 9.71 (−7.14 to 26.56) 0.237
BF >3 months (% difference) 9.92 (−4.54 to 24.39) 0.159 9.67 (−5.62 to 24.95) 0.194
FRC§ (L)
No BF (mean) 1.99 (1.87 to 2.12) 1.96 (1.79 to 2.13)
BF ≤3 months (% difference) 3.03 (−5.57 to 11.64) 0.483 4.72 (−5.12 to 14.55) 0.336
BF >3 months (% difference) 6.58 (−1.89 to 15.06) 0.116 5.76 (−3.36 to 14.87) 0.203
RV§ (L)
No BF (mean) 1.11 (1.01 to 1.21) 1.08 (0.96 to 1.20)
BF ≤3 months (% difference) −1.27 (−12.62 to 10.09) 0.828 −0.59 (−12.75 to 11.57) 0.924
BF >3 months (% difference) 8.32 (−3.53 to 20.18) 0.152 11.27 (−1.22 to 23.75) 0.062
TLC§ (L)
No BF (mean) 4.31 (4.11 to 4.51) 4.38 (4.15 to 4.62)
BF ≤3 months (% difference) 3.00 (−3.13 to 9.13) 0.330 4.36 (−1.59 to 10.31) 0.143
BF >3 months (% difference) 6.13 (0.12 to 12.14) 0.039 6.57 (0.99 to 12.14) 0.017
ADC§ (cm2/s)
No BF (mean) 0.09 (0.09 to 0.10) 0.09 (0.08 to 0.10)
BF ≤3 months (% difference)
Absolute ADC value 3.00 (−3.58 to 9.57) 0.365 0.59 (−6.31 to 7.49) 0.867
Average alveolar size¶ 7.38 (−8.45 to 24.71) 1.45 (−14.51 to 19.03)
BF >3 months (% difference)
Absolute ADC value 0.69 (−5.43 to 6.81) 0.824 1.88 (−4.56 to 8.32) 0.563
Average alveolar size¶ 1.69 (−12.52 to 17.17) 4.64 (−10.72 to 21.18)
*The analyses were performed using the natural logarithm of the outcome variable; the estimates were back-transformed from the logarithmic
scale to the original scale, therefore the means represent the geometric means, not the arithmetic ones.
†In the basic model we adjusted for age, sex and height.
‡In the adjusted model we included, additionally, preterm status, birth weight, Townsend score, smoking during pregnancy, maternal asthma,
maternal ethnicity and early-onset wheeze (wheezing history with onset during the first year of life).
§All analysis were performed using the natural logarithm; the estimates were back-transformed from the logarithmic scale to the original scale,
therefore the coefficients are multiplicative (they represent ratios; eg, in the basic model, participants breastfed ≤3 months had an ADC
absolute value 3% higher than participants who were not breastfed).
¶Calculated with the formula ADC ratio=(volume ratio)0.415, see Narayanan et al.13
ADC, apparent diffusion coefficient; BF, breastfeeding; FEF50, forced mid-expiratory flow; FEV1, forced expiratory volume at 1 s; FRC,
functional residual capacity; FVC, forced vital capacity; RV, residual volume; TLC, total lung capacity.
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lung volumes. Although the analysis adjusted for pres-
ence of maternal asthma, we did not have information
on asthma severity in the mother.
Strengths and limitations
A strength of this study is the large range of lung mea-
surements, including spirometry and plethysmography
and in vivo measurements reﬂecting alveolar dimen-
sion.13 14 Furthermore, the study was able to consider
important potential confounding including early onset
of wheeze, through which we attempted to control for
possible reverse causation.12
The main limitation is the small sample size which was
due to the complexity and cost of the techniques
involved. While the study had been adequately powered
to assess potential age-related changes of alveolar dimen-
sions 13 and differences between term and preterm chil-
dren,14 it was probably too small to detect minor
differences resulting from duration of breastfeeding in
such a distal outcome as lung function at school age.
This was further complicated by the attempt to deter-
mine if the association is inﬂuenced by maternal
asthma, performing an analysis with an interaction term;
there were only seven participants of mothers with
asthma who had been breastfed over 3 months (table 1).
Table 3 Association between breastfeeding and lung function measurements by maternal asthma, fully adjusted model with
interaction
Lung function (unit)
Mothers without asthma Mothers with asthma
estimate (CI) estimate (CI) p-interaction
FVC* (L)
No BF (mean) 3.44 (3.18 to 3.70) 3.35 (3.01 to 3.69)
BF ≤3 months (% difference) 2.38 (– 6.37 to 11.13) 8.54 (– 5.68 to 22.75) 0.471
BF >3 months (% difference) 3.09 (– 4.93 to 11.10) 6.59 (– 7.92 to 21.09) 0.689
FEV1* (L)
No BF (mean) 2.97 (2.73 to 3.20) 2.90 (2.59 to 3.21)
BF ≤3 months (% difference) 5.27 (– 4.18 to 14.71) 3.80 (– 10.48 to 18.07) 0.869
BF >3 months (% difference) 3.23 (– 5.19 to 11.65) 12.88 (– 3.25 to 29.01) 0.308
FEF50* (L/s)
No BF (mean) 3.54 (2.97 to 4.12) 3.40 (2.66 to 4.14)
BF ≤3 months (% difference) 11.10 (– 9.47 to 31.66) 1.15 (– 27.30 to 29.61) 0.591
BF >3 months (% difference) 4.20 (– 13.21 to 21.60) 31.27 (– 7.11 to 69.65) 0.198
FRC* (L)
No BF (mean) 1.99 (1.79 to 2.20) 1.98 (1.71 to 2.26)
BF ≤3 months (% difference) 1.87 (– 9.90 to 13.64) 9.90 (– 9.60 to 29.40) 0.490
BF >3 months (% difference) 2.45 (– 8.35 to 13.24) 15.20 (– 6.01 to 36.40) 0.299
RV* (L)
No BF (mean) 1.12 (0.97 to 1.26) 1.08 (0.89 to 1.27)
BF ≤3 months (% difference) −4.98 (– 19.15 to 9.18) 6.67 (– 17.75 to 31.10) 0.414
BF >3 months (% difference) 4.73 (– 9.51 to 18.97) 31.65 (0.36 to 62.93) 0.117
TLC* (L)
No BF (mean) 4.44 (4.17 to 4.72) 4.38 (4.02 to 4.75)
BF ≤3 months (% difference) 2.07 (– 5.08 to 9.23) 9.32 (– 2.45 to 21.08) 0.303
BF >3 months (% difference) 4.65 (– 2.04 to 11.34) 11.36 (– 1.08 to 23.80) 0.365
ADC* (cm2/s)
No BF (mean) 0.09 (0.08 to 0.10) 0.09 (0.08 to 0.10)
BF ≤3 months (% difference)
absolute ADC value 1.41 (– 6.87 to 9.70) −4.00 (– 16.12 to 8.13) 0.437
average alveolar size† 3.41 (– 15.82 to 24.98) 1.69 (– 12.52 to 17.17)
BF >3 months (% difference)
absolute ADC value −0.47 (– 7.89 to 6.96) 11.04 (– 3.61 to 25.70) 0.174
average alveolar size† −1.20 (– 17.98 to 17.70) 28.58 (– 8.45 to 73.50)
In this model we adjusted for age, sex, height, preterm status, birth weight, Townsend score, smoking during pregnancy, maternal asthma,
maternal ethnicity, and early-onset wheeze (wheezing history with onset during the first year of life) and included an interaction term between
breastfeeding and maternal asthma. The means and coefficients for the groups of children of mother with and without asthma were calculated
using the regression coefficients for breastfeeding, maternal asthma and the interaction term, using the command lincom in Stata, which
computes point estimates, CIs and p-values for linear combinations of coefficients.
*All analyses were performed using the natural logarithm; the estimates were back-transformed from the logarithmic scale to the original scale,
therefore the coefficients are multiplicative (they represent ratios; eg, in children of mothers without asthma, participants breastfed ≤3 months
had an ADC value 1.4% higher than participants who were not breastfed)
†The average alveolar size was calculated with the formula ADC ratio=(volume ratio)0.415, see Narayanan et al.13
ADC, apparent diffusion coefficient; BF, breastfeeding; FEF50, forced mid-expiratory flow; FEV1, forced expiratory volume at 1 second; FRC,
functional residual capacity; FVC, forced vital capacity; p-int, p-interaction; RV, residual volume; TLC, total lung capacity.
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Another limitation is a possible recall bias in reporting
duration of breastfeeding. The participants reported
duration of breastfeeding when the children were
1–4 years old. However, the question had shown an
excellent short-term repeatability in our cohort, with a
Cohen’s κ of 0.96 21 and there is independent evidence
suggesting that long-term recall of breastfeeding is
excellent.22
Diffusion-weighted 3HeMR uses the degree of restric-
tion to diffusion of 3He as a proxy for dimensions of the
enclosing structure. It follows that the diffusion displace-
ment, s, should be of a similar order of magnitude to
the distance between the barriers. If ‘s’ is too small, the
3-He molecules are not restricted by the barriers and
ADC approximates free diffusion coefﬁcient, D. If ‘s’ is
too large, it is affected by the structures outside the bar-
riers. Parra-Robles et al23 contended that the diffusion
time employed in this study would result in ‘s’ that
would be sensitive to structures outside the alveoli.
However, ‘s’ in our case is only 1.58 times larger than
they suggested (because of the square root relation-
ship)24 Also, while it was true that some of the 3He
atoms in our study do sample the space outside an indi-
vidual alveolus and may move to the alveolar duct space,
the measurements still reﬂect alveolar dimensions as the
alveolar duct does not have an independent wall. The
ultrastructure of the periphery of the lung is made up of
alveolar septae. As long as the alveolar duct dimension
does not increase or decrease independent of alveolar
dimensions, our ADC measurements are valid proxies of
alveolar dimensions. This is explored in further detail in
our reply24 to Parra-Robles et al23
The relationship between ADC and volume was
derived by measuring ADC in children at different levels
of inﬂation.13 Using this relationship to extrapolate
alveolar volume ratio between participants from ADC
ratio assumes similar alveolar geometry across partici-
pants, and therefore alveolar volume ratio should be
interpreted with caution.
A hypothesis that could not be explored in this study is
that a possible association of breastfeeding with lung func-
tion measurement is age dependent, that is, the associ-
ation might be present (or stronger) at younger age,
compared with older ages. Unfortunately, despite the
large age range of our participants, the size of the sample
against which we could test this hypothesis is too small; for
example, only ﬁve participants were 10 years or younger.
While not providing a deﬁnite answer to the research
question, the study offered hints that in children of
mothers with asthma, those who are breastfed might have
larger lung volumes, and it opened the path towards
investigating the possible mechanisms involved. Further
investigations with larger sample sizes are essential to
answer this important question. Although the differences
in lung volumes and alveolar size might be small for indi-
vidual children, if these are conﬁrmed in a larger study it
would have important consequences for public health
since the proportion of women with asthma is high.
Figure 1 Association between breastfeeding and lung function measurements by maternal asthma, fully adjusted model with
interaction. The graph represents the adjusted means and CIs for each breastfeeding category (from left to right: none,
≤3 months and >3 months), in the entire sample (blue diamonds) and stratified by children of mothers with no asthma (green
squares) and children of mothers with asthma (red triangles). The estimates come from the adjusted model with interaction.
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